Cutting-edge technology revolutionizes COVID-19 diagnosis through lung ultrasound images, offering swift and accurate detection. Researchers at Johns Hopkins University developed an automated tool akin to facial recognition, which swiftly identifies COVID-19 indicators in lung…
Continue Reading
The NIH-backed study exposes how COVID-19 induces heart damage via inflammation rather than direct infection. Investigating SARS-CoV-2-associated ARDS, researchers find cardiac macrophage dysregulation, irrespective of viral presence. They discern that severe lung inflammation alone…
Continue Reading
[embedded content]
What You Should Know:
– Google Health and Apollo Radiology International are joining forces to tackle some of the country’s biggest health challenges – tuberculosis (TB), lung cancer, and breast cancer – using AI-powered…
Continue Reading
Background: Patient engagement attrition in mobile health (mHealth) remote patient monitoring (RPM) programs decreases program benefits. Systemic disparities lead to inequities in RPM adoption and use. There is an urgent need to understand patients’…
Continue Reading
What You Should Know:
– Lunit (KRX:328130.KQ), a provider of AI-powered cancer diagnostics and therapeutics solutions, announced today two significant commercial agreements that mark its continued European expansion.
– These strategic deals will bring Lunit’s AI-powered…
Continue Reading
By Shania Kennedy
March 13, 2024 – A research team from Washington University School of Medicine in St. Louis has developed a deep learning (DL)-based approach to help predict which patients with non-small cell lung cancer…
Continue Reading
By Shania Kennedy
March 11, 2024 – Researchers from Mount Sinai have been awarded a four-year, $3 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to develop…
Continue Reading
Pioneering AIxSCAN, Inc. introduces the ARC60, an AI-driven tomosynthesis X-ray imaging system poised to revolutionize lung disease diagnosis. Clinical trials demonstrate promising results, igniting anticipation for FDA approval in 2024. Supported by cutting-edge technology…
Continue Reading
Experience the forefront of medical imaging with AIxSCAN’s groundbreaking ARC60 technology. Commencing clinical trials in late 2023, AIxSCAN, Inc. has garnered early success in imaging precision and consistency. Backed by additional seed funding and…
Continue Reading
In 2020, lung cancer, the foremost cause of global cancer-related deaths, took 1.7 million lives, surpassing fatalities from the next three deadliest cancers combined. Early detection significantly improves the five-year survival rate, increasing from…
Continue Reading
